Increased transcriptional signalling from Stat3 in prostate cancer leads to increased expression of Fn and its receptor αvβ6, thus increased cell migration, anchorage independent growth and epithelial mesenchymal transition (EMT), which were inhibited by an anti-αvβ6 antibody [48]. This evidence concerns the gene FN1 and prostate cancer.